Status:

COMPLETED

Dyspnea Assessment in Hemodialysis Patients

Lead Sponsor:

London Health Sciences Centre Research Institute OR Lawson Research Institute of St. Joseph's

Conditions:

Dyspnea; Uremic

End Stage Renal Disease

Eligibility:

All Genders

18+ years

Brief Summary

Shortness of breath is very common among patients on dialysis for kidney failure; however, its causes are often not understood. This study will explore the lungs and the heart of these patients to det...

Detailed Description

Rationale: The available evidence suggest that End-Stage Renal Disease (ESRD) and hemodialysis (HD) have harmful effects on the lungs; the investigators hypothesize that these recurring pulmonary ins...

Eligibility Criteria

Inclusion

  • Inclusion Criteria:
  • Age equal to or greater than 18 years.
  • Dialysis vintage equal to or greater than 3 months.
  • Exclusion Criteria
  • Smoking history of more than 10 packs/year.
  • Active tobacco and/or cannabis smoking.
  • Diagnosed chronic pulmonary disease.
  • Severe heart failure (NYHA class IV)
  • Active infection (including tuberculosis) or malignancy.
  • Pregnancy.
  • Inability to give consent or understand written information.
  • Peripheral oxygen saturation (by pulse oxymetry) dropping below 80% when performing a 12-seconds breathhold.
  • Inability to perform spirometry or plethysmography maneuvers.
  • Inability to tolerate MRI due to patient size and/or known history of claustrophobia.
  • Subject has an implanted mechanically, electrically or magnetically activated device or any metal in their body which cannot be removed, including but not limited to pacemakers, neurostimulators, biostimulators, implanted insulin pumps, aneurysm clips, bioprosthesis, artificial limb, metallic fragment or foreign body, shunt, surgical staples (including clips or metallic sutures and/or ear implants.).

Exclusion

    Key Trial Info

    Start Date :

    March 29 2019

    Trial Type :

    OBSERVATIONAL

    Allocation :

    ACTUAL

    End Date :

    February 25 2020

    Estimated Enrollment :

    7 Patients enrolled

    Trial Details

    Trial ID

    NCT03773991

    Start Date

    March 29 2019

    End Date

    February 25 2020

    Last Update

    August 15 2024

    Active Locations (1)

    Enter a location and click search to find clinical trials sorted by distance.

    Page 1 of 1 (1 locations)

    1

    London Health Sciences Centre

    London, Ontario, Canada